BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 36276159)

  • 1. Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia.
    Schleicher O; Horndasch A; Krumbholz M; Sembill S; Bremensdorfer C; Grabow D; Erdmann F; Karow A; Metzler M; Suttorp M
    Front Oncol; 2022; 12():963223. PubMed ID: 36276159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation.
    Diep PP; Rueegg CS; Burman MM; Brinch L; Bø K; Fosså K; Landrø L; Loge JH; Lund MB; Massey RJ; Myrdal OH; Pathak M; Rimstad L; Tanem KE; Tjønnfjord GE; Aaløkken TM; Ruud E
    J Adolesc Young Adult Oncol; 2023 Feb; 12(1):66-75. PubMed ID: 35544321
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation.
    Gruber I; Koelbl O; Herr W; Holler E; Edinger M; Wolff D
    Radiat Oncol; 2022 Nov; 17(1):195. PubMed ID: 36447269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia.
    Schleicher O; Horndasch A; Krumbholz M; Sembill S; Bremensdorfer C; Grabow D; Erdmann F; Karow A; Metzler M; Suttorp M
    Front Oncol; 2022; 12():1116757. PubMed ID: 36591451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late Effects in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation for Nonmalignant Diseases: Proxy- and Patient-Reported Outcomes.
    Bense JE; Haverman L; von Asmuth EGJ; Louwerens M; Luijten MAJ; Stiggelbout AM; Lankester AC; de Pagter APJ
    Transplant Cell Ther; 2023 Mar; 29(3):186.e1-186.e10. PubMed ID: 36587742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study.
    Valkova V; Jircikova J; Trnkova M; Steinerova K; Keslova P; Lanska M; Koristek Z; Raida L; Krejci M; Kruntoradova K; Dolezal T; Benesova K; Cetkovsky P; Trneny M
    Neoplasma; 2016; 63(5):743-51. PubMed ID: 27468878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of infectious diseases and vaccination uptake in long-term hematopoietic stem cell transplant survivors in Australia.
    Dyer G; Gilroy N; Brice L; Kabir M; Gottlieb D; Huang G; Hogg M; Brown L; Greenwood M; Larsen SR; Moore J; Hertzberg M; Tan J; Ward C; Kerridge I
    Transpl Infect Dis; 2019 Apr; 21(2):e13043. PubMed ID: 30585673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Recipient Health-Related Quality of Life and Donor-Recipient Relationship following Sibling Pediatric Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Pieczonka A; Barańska M; Wachowiak J
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):401-406. PubMed ID: 31622770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
    Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study.
    Bonifazi F; Solano C; Wolschke C; Sessa M; Patriarca F; Zallio F; Nagler A; Selleri C; Risitano AM; Messina G; Bethge W; Herrera P; Sureda A; Carella AM; Cimminiello M; Guidi S; Finke J; Sorasio R; Ferra C; Sierra J; Russo D; Benedetti E; Milone G; Benedetti F; Heinzelmann M; Pastore D; Jurado M; Terruzzi E; Narni F; Völp A; Ayuk F; Ruutu T; Kröger N
    Lancet Haematol; 2019 Feb; 6(2):e89-e99. PubMed ID: 30709437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small airways dysfunction in long-term survivors of pediatric stem cell transplantation.
    Uhlving HH; Mathiesen S; Buchvald F; Green K; Heilmann C; Gustafsson P; Müller K; Nielsen KG
    Pediatr Pulmonol; 2015 Jul; 50(7):704-12. PubMed ID: 24846684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular Chronic Graft-versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes after Allogeneic Hematopoietic Cell Transplantation.
    Jeppesen H; Gjærde LK; Lindegaard J; Julian HO; Heegaard S; Sengeløv H
    Transplant Cell Ther; 2022 Dec; 28(12):833.e1-833.e7. PubMed ID: 36002105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell Transplantation.
    Forgeard N; Jestin M; Vexiau D; Chevillon F; Ricadat E; Peffault de Latour R; Robin M; Sicre de Fontbrune F; Xhaard A; Michonneau D; Boissel N; Poirot C; Dhédin N
    Transplant Cell Ther; 2021 May; 27(5):432.e1-432.e6. PubMed ID: 33789835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia.
    Boyiadzis M; Arora M; Klein JP; Hassebroek A; Hemmer M; Urbano-Ispizua A; Antin JH; Bolwell BJ; Cahn JY; Cairo MS; Cutler CS; Flowers ME; Gale RP; Herzig R; Isola LM; Jacobsohn DA; Jagasia MH; Klumpp TR; Lee SJ; Petersdorf EW; Santarone S; Spellman SR; Schouten HC; Verdonck LF; Wingard JR; Weisdorf DJ; Horowitz MM; Pavletic SZ
    Clin Cancer Res; 2015 May; 21(9):2020-8. PubMed ID: 25348512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic stem cell transplant for chronic myeloid leukemia as a still promising option in the era of the new target therapy.
    Stamatović D; Balint B; Tukić L; Elez M; Tarabar O; Todorović M; Todorić-Zivanović B; Ostojić G; Tatomirović Z; Marjanović S; Malesević M
    Vojnosanit Pregl; 2012 Jan; 69(1):37-42. PubMed ID: 22397295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
    Nair AP; Barnett MJ; Broady RC; Hogge DE; Song KW; Toze CL; Nantel SH; Power MM; Sutherland HJ; Nevill TJ; Abou Mourad Y; Narayanan S; Gerrie AS; Forrest DL
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1437-44. PubMed ID: 25865648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia.
    Dyer G; Gilroy N; Bradford J; Brice L; Kabir M; Greenwood M; Larsen SR; Moore J; Hertzberg M; Kwan J; Brown L; Hogg M; Huang G; Tan J; Ward C; Kerridge I
    Br J Haematol; 2016 Feb; 172(4):592-601. PubMed ID: 26847746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of Autoantibody Expression During Long-Term Follow-Up in Paediatric ALL Patients After Allogeneic Haematopoietic Stem Cell Transplantation.
    Lawitschka A; Ronceray L; Bauer D; Rittenschober M; Zubarovskaya N; Geyeregger R; Pickl WF; Kuzmina Z
    Front Pediatr; 2021; 9():788360. PubMed ID: 34993166
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparable Outcomes After Alternative and Matched Sibling Donor Hematopoietic Stem Cell Transplantation and the Role of Molecular Measurable Residual Disease for Acute Myeloid Leukemia in Elderly Patients.
    Cho BS; Yahng SA; Min GJ; Park S; Park SS; Shin SH; Jeon YW; Yoon JH; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim M; Kim Y; Kim HJ
    Transplant Cell Ther; 2021 Sep; 27(9):774.e1-774.e12. PubMed ID: 34082159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis.
    Srinivasan A; Raffa E; Wall DA; Schechter T; Ali M; Chopra Y; Kung R; Chiang KY; Krueger J
    Transplant Cell Ther; 2022 Mar; 28(3):158.e1-158.e9. PubMed ID: 34838785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.